<DOC>
	<DOCNO>NCT00718705</DOCNO>
	<brief_summary>The purpose study test effectiveness antibiotic treatment ( Josamycin ) case positive PCR Ureaplasma spp . and/or Mycoplasma hominis second quarter risk premature birth .</brief_summary>
	<brief_title>Reduction Spontaneous Prematurity Antibiotic Treatment ( Josamycin )</brief_title>
	<detailed_description>Infection would cause 40 % spontaneous premature delivery . The physiopathological hypothesis accept premature ascent present bacteria low genital way towards decidual , foetal membrane amniotic liquid . These bacteria responsible inflammatory reaction interface feto-maternal characterized production proinflammatory cytokine pro-contractants agent ( prostaglandin , oxytocin ) decidual membrane . These mediator cause uterine contraction , maturation uterine collar , rupture membrane premature birth . Several recent publication show one hand Mycoplasma hominis Ureaplasma spp . bacteria frequently find amniotic liquid second quarter pregnancy positive PCR bacteria associate premature birth . A probable assumption would Mycoplasma hominis Ureaplasma spp . cause premature birth infect fetal membrane decidual , activate immune system pro-inflammatory production cytokine . These bacteria sensitive antibiotic treatment . Nevertheless , randomize control trial carry determine wether antibiotic treatment would decrease spontaneous prematurity case positive PCR amniotic liquid .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Josamycin</mesh_term>
	<criteria>Patient old â‰¥ 18 year French speak Women amniocentesis 15 20 week amenorrhoea antenatal diagnosis Affiliated social security equivalent system Karyotype analysis ultrasound morphological normal ( apart minor sign trisomy 21 ) Clear amniotic fluid ( contaminate mother 's blood ) Gestational age 15 WA ( day+0 ) 20 WA ( day+6 ) Patient allergy macrolides Do cure underway macrolide Patient follow pregnancy investigator site Informed consent sign No speak french Having allergy macrolides Having multiple pregnancy Morphological Anomaly Patient consent Lactose Intolerance Not agree participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Prematurity</keyword>
	<keyword>Ureaplasma spp</keyword>
	<keyword>Mycoplasma Hominis</keyword>
	<keyword>Amniotic fluid</keyword>
	<keyword>Josamycine</keyword>
</DOC>